Cargando…

Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer

The anticancer effects of ruxolitinib and calcitriol against breast cancer were reported previously. However, the effect of ruxolitinib and calcitriol combination treatment on various molecular subtypes of breast cancer remains unexplored. In this study, we used MCF-7, SKBR3, and MDA-MB-468 cells to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Jean, Jeon, Ye Won, Suh, Young Jin, Lim, Seung Taek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910493/ https://www.ncbi.nlm.nih.gov/pubmed/35269680 http://dx.doi.org/10.3390/ijms23052535

Ejemplares similares

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast cancer cells
por: Lim, Seung Taek, et al.
Publicado: (2018)

Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update
por: Segovia-Mendoza, Mariana, et al.
Publicado: (2021)

Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer
por: Lim, Seung Taek, et al.
Publicado: (2020)

Cytokines in various molecular subtypes of breast cancer
por: Autenshlyus, Alexsander, et al.
Publicado: (2021)

Volume replacement with diced acellular dermal matrix in oncoplastic breast-conserving surgery: a prospective single-center experience
por: Gwak, Hongki, et al.
Publicado: (2020)

The Prognostic Values of Preoperative Tumor Volume and Tumor Diameter in T1N0 Papillary Thyroid Cancer
por: Lim, Seung Taek, et al.
Publicado: (2017)

Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2020)

A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population
por: Lim, Seung Taek, et al.
Publicado: (2014)

Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1
por: Jeon, Ye Won, et al.
Publicado: (2015)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim
por: Gwak, Hongki, et al.
Publicado: (2022)

Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines
por: Wong, Fu Hou, et al.
Publicado: (2022)

Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2016)

Nomogram for the Prediction of Biochemical Incomplete Response in Papillary Thyroid Cancer Patients
por: Lim, Seung Taek, et al.
Publicado: (2021)

“Calcitriol” Is Not Synonymous with “Vitamin D”
por: Kimball, Samantha M., et al.
Publicado: (2012)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
por: Rehbein, Sarah, et al.
Publicado: (2023)

Neurochemical Effects of Chronic Administration of Calcitriol in Rats
por: Jiang, Pei, et al.
Publicado: (2014)

Patterns of Recurrence after Breast-Conserving Treatment for Early Stage Breast Cancer by Molecular Subtype
por: Noh, Jae Myoung, et al.
Publicado: (2011)

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
por: Suh, Hee-Won, et al.
Publicado: (2012)

Immunomodulatory Mechanisms of Action of Calcitriol in Psoriasis
por: Raychaudhuri, Suravi, et al.
Publicado: (2014)

Mechanistic Effects of Calcitriol in Cancer Biology
por: Díaz, Lorenza, et al.
Publicado: (2015)

The outcomes of dexmedetomidine and calcitriol on flap viability
por: Kotanoğlu, Mustafa Sırrı, et al.
Publicado: (2020)

Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism
por: Antoun, Jacqueline, et al.
Publicado: (2021)

Rapid Nontranscriptional Effects of Calcifediol and Calcitriol
por: Donati, Simone, et al.
Publicado: (2022)

Pembrolizumab Induced Calcitriol-Mediated Hypercalcemia
por: Oommen, Tiffany T., et al.
Publicado: (2023)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats
por: Nakamura, Yoshinari, et al.
Publicado: (2008)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Schneider, Jean, et al.
Publicado: (2020)

The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer
por: Lim, Seung Taek, et al.
Publicado: (2018)

Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism
por: Xiang, Zeli, et al.
Publicado: (2022)

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
por: Kim, Seok Jin, et al.
Publicado: (2019)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to
por: Li, Yujin, et al.
Publicado: (2020)

Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines
por: Jung, Yeon Soo, et al.
Publicado: (2016)

Phase I/II Trial of Ruxolitinib in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer
por: Kearney, Matthew, et al.
Publicado: (2021)

Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro
por: Paucarmayta, Ana, et al.
Publicado: (2020)

Calcitriol Modulates the CD46 Pathway in T Cells
por: Kickler, Karoline, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8htuua1faer34fucke480tm8mi